Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

329 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Phase II trial of irinotecan in patients with progressive or rapidly recurrent colorectal cancer.
Rothenberg ML, Eckardt JR, Kuhn JG, Burris HA 3rd, Nelson J, Hilsenbeck SG, Rodriguez GI, Thurman AM, Smith LS, Eckhardt SG, Weiss GR, Elfring GL, Rinaldi DA, Schaaf LJ, Von Hoff DD. Rothenberg ML, et al. Among authors: hilsenbeck sg. J Clin Oncol. 1996 Apr;14(4):1128-35. doi: 10.1200/JCO.1996.14.4.1128. J Clin Oncol. 1996. PMID: 8648367 Clinical Trial.
p53 mutation and tamoxifen resistance in breast cancer.
Elledge RM, Lock-Lim S, Allred DC, Hilsenbeck SG, Cordner L. Elledge RM, et al. Among authors: hilsenbeck sg. Clin Cancer Res. 1995 Oct;1(10):1203-8. Clin Cancer Res. 1995. PMID: 9815913
Oxidative stress and AP-1 activity in tamoxifen-resistant breast tumors in vivo.
Schiff R, Reddy P, Ahotupa M, Coronado-Heinsohn E, Grim M, Hilsenbeck SG, Lawrence R, Deneke S, Herrera R, Chamness GC, Fuqua SA, Brown PH, Osborne CK. Schiff R, et al. Among authors: hilsenbeck sg. J Natl Cancer Inst. 2000 Dec 6;92(23):1926-34. doi: 10.1093/jnci/92.23.1926. J Natl Cancer Inst. 2000. PMID: 11106684
Array-based gene expression profiling to study aging.
Han E, Hilsenbeck SG. Han E, et al. Among authors: hilsenbeck sg. Mech Ageing Dev. 2001 Jul 31;122(10):999-1018. doi: 10.1016/s0047-6374(01)00215-9. Mech Ageing Dev. 2001. PMID: 11389920
329 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page